title: Predicting benefit from imatinib: are we close?
authors.affiliation: Feinberg School of Medicine, Northwestern University , Chicago, IL , USA.
authors.forename: Mitul D
authors.initials: MD
authors.lastname: Gandhi
authors.forename: Virginia G
authors.initials: VG
authors.lastname: Kaklamani
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B / Q000235:genetics*; D001549:Benzamides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D027702:Organic Cation Transporter 1 / Q000235:genetics*; D010879:Piperazines / Q000627:therapeutic use*; D020641:Polymorphism, Single Nucleotide; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D018435:ATP Binding Cassette Transporter, Subfamily B; D001549:Benzamides; D027702:Organic Cation Transporter 1; D010879:Piperazines; D011743:Pyrimidines